Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.


Date Title Topic
06 Sep 2017 ESMO 2017 Press Release: Some Stroke Survivors May Have Underlying Cancer Epidemiology/Etiology/Cancer Prevention
06 Sep 2017 Written Treatment Summaries Are Crucial to Meeting Needs for Information on Recurrence, Fertility, and Late Treatment Effects in Adolescent and Young Adult Cancer Survivors Cancer in Special Situations
06 Sep 2017 ESMO 2017 Press Release: Alectinib: ALEX and ALUR Trials Show CNS Benefit in NSCLC Lung and other thoracic tumours
05 Sep 2017 FDA Approves Gemtuzumab Ozogamicin for CD33-positive AML Haematologic malignancies - Anticancer agents & Biologic therapy
05 Sep 2017 ESMO 2017 Press Release: MIRO Trial: 3-year Outcomes Favour Laparoscopic Surgery for Oesophageal Cancer Gastrointestinal cancers
04 Sep 2017 Ribociclib Receives EU Approval as First-Line Treatment for HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
04 Sep 2017 ESMO 2017 Press Release: ICON8 Trial Reaffirms Standard Dosing in Ovarian Cancer Chemo Gynaecologic malignancies
03 Sep 2017 ESMO 2017 Press Release: Study in Early Stage Breast Cancer Shows That Even Small Tumours Can Be Aggressive Breast cancer
02 Sep 2017 ESMO 2017 Press Release: Study Highlights Overuse of Tumour Marker Tests in Primary and Secondary Care Epidemiology/Etiology/Cancer Prevention
01 Sep 2017 FDA Approves Tisagenlecleucel for B-Cell ALL and Tocilizumab for Cytokine Release Syndrome Haematologic malignancies - Palliative and supportive care - Cancer Immunology and Immunotherapy
01 Sep 2017 ESMO 2017 Media Alert: Updated ESMO Magnitude of Clinical Benefit Scale Set to Evaluate Single-arm Studies
31 Aug 2017 Indels Provide Highly Immunogenic Neoantigens and May Be Potential Biomarkers of Immunotherapy Response Translational research - Cancer Immunology and Immunotherapy
31 Aug 2017 ESMO 2017 Press Release: IFCT-0302 results question role of CT-scan in NSCLC post-surgery follow-up Lung and other thoracic tumours
30 Aug 2017 NICE Issues Technology Appraisal Guidance on Olaratumab in Combination with Doxorubicin for Treating Advanced STS Sarcomas - Anticancer agents & Biologic therapy
30 Aug 2017 Media Alert: ESMO 2017 Poster and Oral Abstracts Published Online Tonight